Originator Organization Tallac Therapeutics, Inc.Startup |
Active Organization Tallac Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | Tallac Therapeutics, Inc.Startup | 26 Feb 2021 |